Journal of International Oncology››2015,Vol. 42››Issue (10): 726-729.doi:10.3760/cma.j.issn.1673-422X.2015.10.002
Previous ArticlesNext Articles
Wei Cunzhi, Cai Defeng, Qu Jinwen, Xiao Shiqiang, Wang Jianhong
Online:
2015-10-08Published:
2015-09-08Contact:
Wei Cunzhi E-mail:weicunzhi666666@126.comWei Cunzhi, Cai Defeng, Qu Jinwen, Xiao Shiqiang, Wang Jianhong. Therapeutic effect and prognostic factors for patients with mucoepidermoid carcinoma of parotid gland[J]. Journal of International Oncology, 2015, 42(10): 726-729.
[1] 朱俏, 张建国, 张杰, 等. 肿瘤保守切除联合放射性粒子植入治疗腮腺癌[J]. 中华放射医学与防护杂志, 2014, 34(4): 283-285. [2] 石慧烽, 胡海生, 王中和. 腮腺癌术后5放射野调强放射治疗的临床观察[J]. 口腔颌面外科杂志, 2014, 24(1): 52-55. [3] Bjrndal K, Krogdahl A, Therkildsen MH, et al. Salivary gland carcinoma in Denmark 1990—2005: outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA)[J]. Oral Oncol, 2012, 48(2): 179-185. [4] Herman MP, Werning JW, Morris CG, et al. Elective neck management for highgrade salivary gland carcinoma[J]. Am J Otolaryngol, 2013, 34(3): 205-208. [5] Chen AM, Bucci MK, Quivey JM, et al. Longterm outcome of patients treated by radiation therapy alone for salivary gland carcinomas[J]. Int J Radiat Oncol Biol Phys, 2006, 66(4): 1044-1050. [6] Gomez DR, Katabi N, Zhung J, et al. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland[J]. Cancer, 2009, 115(10): 2128-2137. [7] Terhaard CH, Lubsen H, Rasch CR, et al. The role of radiotherapy in the treatment of malignant salivary gland tumors[J]. Int J Radiat Oncol Biol Phys, 2005, 61(1): 103-111. |
[1] | Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma: a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua.Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy[J]. Journal of International Oncology, 2024, 51(5): 257-266. |
[4] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[5] | Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei.Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction[J]. Journal of International Oncology, 2024, 51(4): 193-197. |
[6] | Wang Kun, Zhou Zhongxin, Zang Qiwei.Predictive value of serum TGF-β1 and VEGF levels in patients with non-small cell lung cancer after single-port thoracoscopic radical resection[J]. Journal of International Oncology, 2024, 51(4): 198-203. |
[7] | Wan Fang, Yang Gang, Li Rui, Wan Qijing.Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer[J]. Journal of International Oncology, 2024, 51(4): 204-209. |
[8] | Yao Yixin, Shen Yulin.Predictive value of serum SOCS3 and TXNIP levels for the prognosis of patients with hepatocellular carcinoma treated with TACE[J]. Journal of International Oncology, 2024, 51(4): 217-222. |
[9] | Yan Aiting, Wang Cuizhu, Liu Chungui, Lu Xiaomin.Clinical efficacy and safety of camrelizumab and sintilimab in the treatment of advanced non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 137-142. |
[10] | Sun Weiwei, Yao Xuemin, Wang Pengjian, Wang Jing, Jia Jinghao.Exploration of prognostic factors and nomogram construction for advanced non-small cell lung cancer treated with immunotherapy based on hematologic indexes[J]. Journal of International Oncology, 2024, 51(3): 143-150. |
[11] | Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 175-180. |
[12] | Peng Qin, Cai Yuting, Wang Wei.Advances on KPNA2 in liver cancer[J]. Journal of International Oncology, 2024, 51(3): 181-185. |
[13] | Chen Boguang, Wang Sugui, Zhang Yongjie.Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer[J]. Journal of International Oncology, 2024, 51(2): 73-82. |
[14] | Jiang Xi, Wu Yongcun, Liang Yan, Chu Li, Duan Yingxin, Wang Lijun, Huo Junjie.Impact of pembrolizumab combined with chemotherapy on angiogenesis and circulating endothelial cells in patients with advanced non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(2): 89-94. |
[15] | Jin Xudong, Chen Zhongjian, Mao Weimin.Research progress on the role of MTAP in malignant mesothelioma[J]. Journal of International Oncology, 2024, 51(2): 99-104. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||